Resources

Results per page

Application Notes

From ore to metal

10 Jan 2023

Application Notes

High-throughput detection of degraded polysorbate in biological formulations with FMM

9 Jan 2023

Application Notes

A flexible approach to bioanalysis

9 Jan 2023

Application Notes

Case study: Efficiently performing two global approval studies in prostate cancer patients

9 Jan 2023

Application Notes

A flexible approach to early phase clinical trials

9 Jan 2023

Application Notes

A flexible approach to global regulatory affairs

9 Jan 2023

Application Notes

A flexible approach to neuropharmacology

9 Jan 2023

Application Notes

A flexible approach to phase II-IV clinical trials

9 Jan 2023

Application Notes

A flexible approach to toxicology and preclinical services

9 Jan 2023

White Papers

Antibody drug conjugates

9 Jan 2023

White Papers

CNS drug development

9 Jan 2023

White Papers

Five criteria to use when selecting a CRO for a gene therapy study

9 Jan 2023

White Papers

Human AME (mass balance) studies

9 Jan 2023

White Papers

Selecting the location of a phase I clinical trial site for EU registration

9 Jan 2023

White Papers

Pharmacokinetic studies in patients

9 Jan 2023

White Papers

Plasma protein binding

9 Jan 2023

White Papers

RNAi therapeutics

9 Jan 2023

White Papers

Three lessons to help accelerate pharmaceutical breakthroughs for CNS disorders

9 Jan 2023

White Papers

Regulatory considerations in gene and cellular therapy development

9 Jan 2023

White Papers

Therapeutic oligonucleotide metabolite identification, profiling, and quantitation

9 Jan 2023

Infographics

Cas9 plasmids vs proteins for CRISPR gene editing experiments

9 Jan 2023

Application Notes

Analysis of polar compounds using an Agilent InfinityLab Poroshell 120 Aq-C18 column with improved and reliable performance

9 Jan 2023

Application Notes

A flexible approach to biotherapeutics and vaccines

6 Jan 2023

Application Notes

Analysis solutions to fight food fraud

6 Jan 2023

Application Notes

Human liver microphysiological system for predicting the drug-induced liver toxicity of differing drug modalities

6 Jan 2023

Resources

Resources Filter

Search

From ore to metal

High-throughput detection of degraded polysorbate in biological formulations with FMM

A flexible approach to bioanalysis

Case study: Efficiently performing two global approval studies in prostate cancer patients

A flexible approach to early phase clinical trials

A flexible approach to global regulatory affairs

A flexible approach to neuropharmacology

A flexible approach to phase II-IV clinical trials

A flexible approach to toxicology and preclinical services

Antibody drug conjugates

CNS drug development

Five criteria to use when selecting a CRO for a gene therapy study

Human AME (mass balance) studies

Selecting the location of a phase I clinical trial site for EU registration

Pharmacokinetic studies in patients

Plasma protein binding

RNAi therapeutics

Three lessons to help accelerate pharmaceutical breakthroughs for CNS disorders

Regulatory considerations in gene and cellular therapy development

Therapeutic oligonucleotide metabolite identification, profiling, and quantitation

Cas9 plasmids vs proteins for CRISPR gene editing experiments

Analysis of polar compounds using an Agilent InfinityLab Poroshell 120 Aq-C18 column with improved and reliable performance

A flexible approach to biotherapeutics and vaccines

Analysis solutions to fight food fraud

Human liver microphysiological system for predicting the drug-induced liver toxicity of differing drug modalities

Resources

Resources FilterResources Filter

Search

From ore to metal

High-throughput detection of degraded polysorbate in biological formulations with FMM

A flexible approach to bioanalysis

Case study: Efficiently performing two global approval studies in prostate cancer patients

A flexible approach to early phase clinical trials

A flexible approach to global regulatory affairs

A flexible approach to neuropharmacology

A flexible approach to phase II-IV clinical trials

A flexible approach to toxicology and preclinical services

Antibody drug conjugates

CNS drug development

Five criteria to use when selecting a CRO for a gene therapy study

Human AME (mass balance) studies

Selecting the location of a phase I clinical trial site for EU registration

Pharmacokinetic studies in patients

Plasma protein binding

RNAi therapeutics

Three lessons to help accelerate pharmaceutical breakthroughs for CNS disorders

Regulatory considerations in gene and cellular therapy development

Therapeutic oligonucleotide metabolite identification, profiling, and quantitation

Cas9 plasmids vs proteins for CRISPR gene editing experiments

Analysis of polar compounds using an Agilent InfinityLab Poroshell 120 Aq-C18 column with improved and reliable performance

A flexible approach to biotherapeutics and vaccines

Analysis solutions to fight food fraud

Human liver microphysiological system for predicting the drug-induced liver toxicity of differing drug modalities

Resources Filter